INVESTIGADORES
BARRIO Maria Marcela
artículos
MORDOH, JOSÉ; SCHWAB, ERIKA; BRAVO, ALICIA INÉS; ARIS, MARIANA; BARRIO, MARÍA MARCELA
Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study
Frontiers in Immunology; Año: 2024 vol. 15
ALICIA INES BRAVO; MARIANA ARIS; MARYLOU PANOUILLOT; MARTINA PORTO; MARIE-CAROLINE DIEU-NOSJEAN; JEAN-LUC TEILLAUD ; MARIA MARCELA BARRIO; JOSÉ MORDOH
HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy
Frontiers in immunology; Lugar: Lausanne; Año: 2023 vol. 14 p. 14 - 15
MORDOH ANA; TRIVIÑO PARDO JUAN CARLOS ; IBEL CARRI; BARRIO MARÍA MARCELA,; MORDOH JOSÉ; ARIS MARIANA
Early contribution of germline and nevi genetic alterations to a rapidly‑progressing cutaneous melanoma patient: a case report
BMC MEDICAL GENOMICS; Lugar: Londres; Año: 2023 vol. 16
IBEL CARRI; ERIKA SCHWAB; ENRIQUE PODAZA; HELI MAGALÍ GARCIA ALVAREZ; JOSE MORDOH,; MORTEN NIELSEN; MARIA MARCELA BARRIO,
Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients
Exploration Of immunology; Lugar: New York; Año: 2023
BORDIGNON, MARÍA B.; PESCE VIGLIETTI, AYELÉN I.; JULIÁ, ESTEFANÍA P.; SANCHEZ, MARÍA B.; RÖLLE, ALEXANDER; MANDÓ, PABLO; SABATINI, LUCIANA; OSTINELLI, ALEXIS; RIZZO, MANGLIO M.; BARRIO, MARÍA M.; MORDOH, JOSÉ; FAINBOIM, LEONARDO; LEVY, ESTRELLA M.
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients
CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2023
GUSTAVO VILLOLDO; MARIA TERESA POMBO; MARIANA ARIS; JOAQUIN CHEMI; PABLO MANDÓ; SUPRIYA NAGARAJU; JUAN CAMEAN; ADRIÁN BURIONI.; DEBORA EGEA; MORA AMAT; JOSE LEÓN MELLADO ; JOSE MORDOH,; ALBERTO VILLARONGA; MARIA MARCELA BARRIO,
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study
ONCOLOGY RESEARCH; Lugar: Henderson, NV; Año: 2023 vol. 31 p. 207 - 220
ANA MORDOH; MARIANA ARIS; IBEL CARRI; ALICIA I. BRAVO; ENRIQUE PODAZA; JUAN C. TRIVIÑO PARDO; GERARDO R. CUETO; MARÍA M. BARRIO; JOSÉ MORDOH
AN UPDATE OF CUTANEOUS MELANOMA PATIENTS TREATED IN ADJUVANCY WITH THE ALLOGENEIC MELANOMA VACCINE VACCIMEL AND PRESENTATION OF A SELECTED CASE REPORT WITH IN-TRANSIT METASTASES
Frontiers in Immunology; Lugar: Laussane; Año: 2022
MADORSKY ROWDO FP; BARÓN A; GALLAGHER SJ; HERSEY P; EMRAN AA; VON EUW EM; BARRIO MM; MORDOH J
EPIGENETIC INHIBITORS ELIMINATE SENESCENT MELANOMA BRAF V600E CELLS THAT SURVIVE LONGTERM BRAF INHIBITION
INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2020 vol. 56 p. 1429 - 1441
PODAZA, ENRIQUE; CARRI, IBEL; ARIS, MARIANA; VON EUW, ERIKA; BRAVO, ALICIA INÉS; BLANCO, PAULA; ORTIZ WILCZYÑSKI, JUAN MANUEL; KOILE, DANIEL; YANKILEVICH, PATRICIO; NIELSEN, MORTEN; MORDOH, JOSÉ; BARRIO, MARÍA MARCELA
Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF
Frontiers in Immunology; Lugar: Lausanne; Año: 2020 vol. 11
ARIS, MARIANA; BRAVO, ALICIA INÉS; GARCIA ALVAREZ, HELI MAGALÍ; CARRI, IBEL; PODAZA, ENRIQUE; BLANCO, PAULA ALEJANDRA; ROTONDARO, CECILIA; BENTIVEGNA, SOFIA; NIELSEN, MORTEN; BARRIO, MARÍA MARCELA; MORDOH, JOSÉ
Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood
Frontiers in Immunology; Lugar: Laussane; Año: 2019 vol. 10
PAMPENA, MARÍA B.; CARTAR, HOLLIDAY C.; CUETO, GERARDO RUBÉN; LEVY, ESTRELLA M.; BLANCO, PAULA A.; BARRIO, MARÍA M.; MORDOH, JOSÉ
Dissecting the immune stimulation promoted by CSF-470 vaccine plus adjuvants in cutaneous melanoma patients: long term antitumor immunity and short term release of acute inflammatory reactants
Frontiers in Immunology; Lugar: Laussane; Año: 2018 vol. 9
ARIS MARIANA; BRAVO AI; PAMPENA MB; BLANCO PA; CARRI I; KOILE D; YANKILEVICH P; LEVY EM; BARRIO MM ; MORDOH J
Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
Frontiers in immunology; Lugar: Lausanne; Año: 2018
ARIS MARIANA; FURMAN DAVID, VON EUW ERIKA, LEVY ESTRELLA, BARRIO MARÍA MARCELA, BIANCHINI MICHELE, MORDOH JOSÉ.; BARRIO MARIA MARCELA
Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma.
Frontiers in Immunology; Lugar: Laussane; Año: 2017 vol. 8
MARÍA B. PAMPENA; MARÍA M. BARRIO ; ESTEFANÍA P. JULIÁ ; PAULA A. BLANCO ; ERIKA M. VON EUW ; JOSÉ MORDOH ; ESTRELLA M LEVY
Early events of the reaction elicited by CSF-470 melanoma vaccine plus adjuvants: An in vitro analysis of immune recruitment and cytokine release.
Frontiers in Immunology; Lugar: Laussane; Año: 2017
JOSÉ MORDOH; MARÍA B. PAMPENA; MARIANA ARIS; PAULA A. BLANCO; MÓNICA LOMBARDO; ERIKA M. VON EUW ; SOLEDAD MAC KEON; MICHELLE YÉPEZ CROW; ALICIA I. BRAVO; JUAN M. O´CONNOR; ANA G. ORLANDO; FRANCO RAMELLO; ESTRELLA M. LEVY; MARÍA M. BARRIO,
Phase II study of adjuvant immunotherapy with the CSF-470 vaccine plus BCG plus rhGM-CSF versus medium-dose interferon alpha 2b in stages IIB, IIC and III cutaneous melanoma patients. A single institution, randomized study
Frontiers in Immunology; Lugar: Lausanne; Año: 2017
ARIS M; BRAVO AI; BARRIO MM; MORDOH J
Inoculation site from a cutaneous melanoma patient treated with an allogeneic therapeutic vaccine: a case report.
Frontiers in Immunology; Lugar: Laussane; Año: 2015 vol. 6 p. 1 - 5
GABRIELA A. PIZZURRO ; IVANA J. TAPIA; LEONARDO SGANGA ; OSVALDO L. PODHAJCER ; JOSÉ MORDOH.; MARÍA M BARRIO
Cytokine-enhanced maturation and migration to the lymph nodes of a dying melanoma cell-loaded human dendritic cell vaccine
CANCER IMMUNOLOGY IMMUNOTHERAPY; Lugar: Berlin; Año: 2015 vol. 64 p. 1393 - 1406
ROBERTI MP; JULIÁ EP; ROCCA YS; AMAT M; BRAVO AI; LOZA J; COLÓ F; LOZA CM; FABIANO V; MAINO M; PODHORZER A; FAINBOIM L; BARRIO MM,; MORDOH J,; LEVY EM
Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.
EUROPEAN JOURNAL OF IMMUNOLOGY; Lugar: Weinheim; Año: 2015 vol. 45 p. 1560 - 1569
BARRIO MM; LEVY EM; MORDOH JOSÉ
Editorial: "Cancer Immunotherapy: Lights and Shadows".
Frontiers in Immunology; Lugar: Lausanne; Año: 2015 vol. 6 p. 1 - 2
ARIS M; BARRIO MM
Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.
Frontiers in immunology; Lugar: Laussane; Año: 2015 vol. 6 p. 1 - 17
PIZZURRO GA; BARRIO MM
Dendritic cell-based vaccine efficacy: aiming for hot spots
Frontiers in Immunology; Lugar: Laussane; Año: 2015 vol. 6 p. 1 - 8
MORDOH, JOSÉ; TAPIA IVANA JAQUELINE; BARRIO MARIA MARCELA
A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment
BMC CANCER; Lugar: Londres; Año: 2013
PIZZURRO GABRIELA A; MADORSKY ROWDO FLORENCIA ; PUJOL-LEREIS LUCIANA ; QUESADA-ALLUÉ LUIS A; COPATI ANDREA M; ROBERTI MARÍA P; TEILLAUD JEAN-LUC; LEVY ESTRELLA M; BARRIO MARÍA M; MORDOH JOSÉ
HIGH LIPID CONTENT OF IRRADIATED HUMAN MELANOMA CELLS DOES NOT AFFECT CYTOKINE-MATURED DENDRITIC CELL FUNCTION.3-15.
CANCER IMMUNOLOGY IMMUNOTHERAPY; Lugar: Berlin; Año: 2013 vol. 62 p. 3 - 15
IVANA J. TAPIA; MARIANA ARIS ; JUAN MARTÍN ARRIAGA ; PAULA A. BLANCO ; FLORENCIA MAZZOBRE; JULIO VEGA ; JOSÉ MORDOH ; MARÍA MARCELA BARRIO
Development of a novel methodology for cryopreservation of melanoma cells applied to CSF470 therapeutic vaccine
CRYOBIOLOGY; Lugar: Amsterdam; Año: 2013 vol. 67 p. 163 - 169
ARIS MARIANA; BARRIO MARÍA MARCELA; MORDOH JOSÉ
Vacuna terapéutica CSF-470 para melanoma cutáneo
Actualizaciones Terapéuticas Dermatológicas; Año: 2013 vol. 36 p. 40 - 43
ARIS MARIANA; BARRIO MARIA MARCELA; MORDOH JOSE
Lessons from cancer immunoediting in Cutaneous Melanoma,
Clinical and Developmental Immunology.; Lugar: Los Angeles; Año: 2012 p. 1 - 14
MARÍA MARCELA BARRIO ; RIAD ABES ; MARINA COLOMBO ; GABRIELA PIZZURRO ; CHARLOTTE BOIX ; MARÍA PAULA ROBERTI ; EMMANUELLE GÉLIZÉ; MARIANA RODRIGUEZ ZUBIETA ; JOSÉ MORDOH; JEAN-LUC TEILLAUD
Human macrophages and dendritic cells can equally present MART-1 antigen to CD8+ T cells after phagocytosis of gamma-irradiated melanoma cells
PLOS ONE; Lugar: San Francisco; Año: 2012 vol. 7 p. 40311 - 40311
J.M. ARRIAGA ; I.A. BRAVO; L. BRUNO; S. MORALES BAYO ; A. HANNOIS ; F. SANCHEZ LORIA ; F. PAIROLA ; E. HUERTAS ; M.P. ROBERTI ; Y.S. ROCCA; M. ARIS; M.M. BARRIO; S. BAFFA TRASCI ; E.M. LEVY ; J. MORDOH; M. BIANCHINI.
"Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes' stage B and C colorectal cancer"
HUMAN PATHOLOGY; Año: 2012 vol. 43 p. 1695 - 1703
MARÍA ROBERTI ; JUAN ARRIAGA ; MICHELE BIANCHINI; DR. HÉCTOR QUINTÁ; ALICIA BRAVO; ESTRELLA LEVY; JOSÉ MORDOH; MARIA MARCELA BARRIO
Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice
CANCER BIOLOGY & THERAPY; Lugar: Austin, Texas; Año: 2012 vol. 13 p. 1123 - 1140
ROBERTI MP; ROCCA YS; AMAT M; PAMPENA MB; LOZA J; COLÓ F; FABIANO V; LOZA CM; ARRIAGA JM; BIANCHINI M; BARRIO MM; BRAVO AI; DOMENICHINI E; CHACÓN R; MORDOH J; LEVY EM.
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients.
BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2012 vol. 136 p. 659 - 671
MARIANA ARIS; MARIANA RODRIGUEZ ZUBIETA; MARINA COLOMBO; JUAN MARTÍN ARRIAGA; MICHELE BIANCHINI; MYRIAM ALPEROVICH; ALICIA I. BRAVO; MARÍA M. BARRIO; JOSÉ MORDOH
MART-1- and gp100-Expressing and -Non-Expressing Melanoma Cells Are Equally Proliferative in Tumors and Clonogenic In Vitro
JOURNAL OF INVESTIGATIVE DERMATOLOGY; Año: 2012 vol. 132 p. 365 - 374
ROBERTI MP; BARRIO MM; BRAVO AI ; ROCCA YS; ARRIAGA JM; BIANCHINI M; MORDOH J; LEVY EM
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
Breast Cancer Res. Treat; Año: 2011 vol. 130 p. 465 - 475
ALEX S POWLESLAND ; MARIA MARCELA BARRIO; JOSÉ MORDOH ; PAUL G HITCHEN; ANNE DELL; KURT DRICKAMER; MAUREEN E TAYLOR
Glycoproteomic characterization of carriers of the CD15/Lewisx epitope on Hodgkin's Reed-Sternberg cells.
BMC BIOCHEMISTRY; Año: 2011 vol. 12 p. 13 - 13
MARIANA ARIS; MARÍA M. BARRIO; JOSÉ MORDOH
CUTANEOUS MELANOMA: A TEST FIELD FOR IMMUNOTHERAPY AND A MEDICAL CHALLENGEh
Current Cancer Therapy reviews; Lugar: The Netherlands; Año: 2010 vol. 6 p. 229 - 242
BARRIO MARIA MARCELA
Melanoma e Inmunidad
ACTA BIOQUíMICA CLíNICA LATINOAMERICANA; Lugar: La plata,¨Provincia de Buenos Aires, Argentina; Año: 2009 vol. 43 p. 351 - 355
LEVY EM; SYCZ G; ARRIAGA JM,; BARRIO MM; VON EUW EM; MORALES SB; GONZÁLEZ M; MORDOH J; BIANCHINI M
Cetuximab-mediated cellular cytotoxicity is inhibited by membrane expression of HLA-E on colon cancer cells.
INNATE IMMUNITY; Año: 2009 vol. 2 p. 91 - 100
BARRIO MARIA MARCELA
Quimiorresistencia del Melanoma
ACTA BIOQUíMICA CLíNICA LATINOAMERICANA; Lugar: Provincia de Buenos Aires, Argentina; Año: 2009 vol. 43 p. 345 - 350
POWLESLAND AS,; HITCHEN PG,; PARRY S,; GRAHAM SA,; BARRIO MM,; ELOLA MT,; MORDOH J,; DELL A,; DRICKAMER K,; TAYLOR ME
Targeted glycoproteomic identification of cancer cell glycosylation.
GLYCOBIOLOGY; Lugar: Oxford, UK; Año: 2009 vol. 19 p. 899 - 909
VON EUW EM, BARRIO MM; FURMAN D; LEVY EM; BIANCHINI M; PEGUILLET I; LANTZ O; VELLICE A; KOHAN A; CHACÓN M; YEE C; WAINSTOK R; MORDOH J
A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of diseas
J Transl Medicine; Año: 2008 vol. 6 p. 6 - 6
LEVY EM; BIANCHINI M; VON EUW EM; BARRIO MM; BRAVO AI; FURMAN D; DOMENICHINI E; MACAGNO C; PNSKY V; ZUCCHINI C; VALVASSORI L; MORDOH J.
Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer
INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 2008 vol. 32 p. 637 - 641
MERCEDES B. FUERTES; MARIA V. GIRART; LUCIANA L. MOLINERO; CAROLINA I. DOMAICA,; LUCAS E. ROSSI; MARIA M. BARRIO; JOSE MORDOH,; GABRIEL A. RABINOVICH; NORBERTO W. ZWIRNER
Intracellular Retention of the NKG2D Ligand MHC Class I Chain-Related Gene A in Human Melanomas Confers Immune Privilege and Prevents NK Cell-Mediated Cytotoxicity
JOURNAL OF IMMUNOLOGY; Año: 2008 vol. 180 p. 4606 - 4614
VON EUW EM, BARRIO MM; FURMAN D; LEVY EM; BIANCHINI M; PEGUILLET I; LANTZ O; VELLICE A; KOHAN A; CHACÓN M; YEE C; WAINSTOK R; MORDOH J
A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of diseas
JOURNAL OF TRANSLATIONAL MEDICINE; Año: 2008 vol. 6 p. 6 - 6
ELOLA MT; CAPURRO MI; BARRIO MM; COOMBS PJ; TAYLOR ME; DRICKAMER K.; MORDOH J
Lewis x Antigen Mediates Adhesion of Human Breast Carcinoma Cells to Activated Endothelium. Possible Involvement of the Endothelial Scavenger Receptor C-type Lectin
BREAST CANCER RESEARCH AND TREATMENT; Año: 2007 vol. 101 p. 161 - 174
VON EUW EM; BARRIO MM; FURMAN D; BIANCHINI M; LEVY EM; YEE C; LI Y; WAINSTOK R; MORDOH J
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes.
JOURNAL OF TRANSLATIONAL MEDICINE; Año: 2007 vol. 5 p. 19 - 19
DIEGO MARTINEZ; MONICA VERMEULEN; ERIKA M VON EUW; JUAN SABATTE; JULIAN MAGGINI; ANA CEBALLOS; ANALIA TREVANI; KAREN NAHMOD; GABRIELA SALAMONE,; MARCELA BARRIO; MIRTA GIORDANO; SEBASTIAN AMIGORENA; JORGE GEFFNER
Extracellular Acidosis Triggers the Maturation of Human Dendritic Cells and the Production of IL-12
JOURNAL OF IMMUNOLOGY; Año: 2007 vol. 179 p. 1950 - 1959
MARÍA M. BARRIO, ; PATRICIA T. DE MOTTA; JULIO KAPLAN; ERIKA M. VON EUW; ALICIA I. BRAVO; REINALDO D. CHACON; JOSÉ MORDOH
A Phase I Study of an Allogeneic Cell Vaccine (VACCIMEL) With GM-CSF in Melanoma Patients
Journal of Immunotherapy; Lugar: New York, NY, U.S.A; Año: 2006 vol. 29 p. 444 - 454
MARIANA RODRÝGUEZ ZUBIETA, DAVID FURMAN, MARCELA BARRIO, ALICIA INES BRAVO, ENZO DOMENICHINI, AND JOSE´ MORDOH
Galectin-3 Expression Correlates with Apoptosis of Tumor-Associated Lymphocytes in Human Melanoma Biopsies
AMERICAN JOURNAL OF PATHOLOGY; Año: 2006 vol. 168 p. 1666 - 1675
ANDRES DEKANTY, MOIRA SAUANE, BELEN CADENAS, FEDERICO COLUCCIO, MARCELA BARRIO, JORGELINA CASALA, MERCEDES PACIENCIA, FLORENCIA ROGERS, OMAR A. COSO, GRACIELA PIWIEN-PILIPUK, PHILIP S. RUDLAND, AND LUIS JIMENEZ DE ASUA
Leukemia Inhibitory Factor Induces DNA Synthesis in Swiss Mouse 3T3 Cells Independently of Cyclin D1 Expression through a Mechanism Involving MEK/ERK1/2 Activation
JOURNAL OF BIOLOGICAL CHEMISTRY; Año: 2006 vol. 281 p. 6136 - 6143
MARÍA M. BARRIO, ; PATRICIA T. DE MOTTA; JULIO KAPLAN; ERIKA M. VON EUW; ALICIA I. BRAVO; REINALDO D. CHACON; JOSÉ MORDOH
A Phase I Study of an Allogeneic Cell Vaccine (VACCIMEL) With GM-CSF in Melanoma Patients
JOURNAL OF IMMUNOTHERAPY; Lugar: New York, NY, U.S.A; Año: 2006 vol. 29 p. 444 - 454
EMMANUELLE BONNIN, NADÈGE GRUEL, SANDRINE MOUTEL, ADRIANA R. MANTEGAZZA, MARCELA M. BARRIO, JOSÉ MORDOH, AND JEAN-LUC TEILLAUD
Generation of functional scFv intrabodies for triggering anti-tumor immunity
METHODS; Año: 2004 vol. 34 p. 225 - 232
ADRIANA R. MANTEGAZZA; MARÍA MARCELA BARRIO; SANDRINE MOUTEL,; LAURA BOVER, MARKUS WECK, PETER BROSSART, JEAN-LUC TEILLAUD, AND JOSE´ MORDOH; MARKUS WECK,; PETER BROSSART,; JEAN-LUC TEILLAUD,; JOSÉ MORDOH
CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells
BLOOD, THE JOURNAL OF THE AMERICAN SOCIETY OF HEMATOLOGY - PRINT; Año: 2004 vol. 104 p. 1183 - 1190
M. M. BARRIO, M. VIAGGI, M. DONALDSON, P. PORTELA, L. BOVER, J. MORDOH, S. G. DE CASTIGLIA
Tumor Imaging with 99mTc-labeled FC-5.01 monoclonal antibody using a single step labeling method
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY; Lugar: Budapest; Año: 2000 vol. 245 p. 337 - 341
MARLA MARCELA BARRIO,; PAULA PORTELA; JOSE MORDOH
Monoclonal Antibody FC-5.01, Directed Against CD63 Antigen, is Internalized into Cytoplasmic Vesicles in the IIB-BR-G Human Breast Cancer Cell Line
HYBRIDOMA; Año: 1998 vol. 17 p. 517 - 525
MARIA MARCELA BARRIO,; ALICIA INES BRAVO, PAULA PORTELA, PETER HERSEY, AND JOSE MORDOH; PAULA PORTELA,; PETER HERSEY; JOSE MORDOH
A New Epitope on Human Melanoma-Associated Antigen CD63/ME491 Expressed by Both Primary and Metastatic Melanoma
HYBRIDOMA; Año: 1998 vol. 17 p. 355 - 363
LAURA BOVER,; MARCELA BARRIO; ALICIA INES BRAV0; IRMA SLAVUTSKY; IRENE LARRIPA,; ARQUÍRNEDES BOLONDI,; MIGUEL AYALA; JOSE MORDOH
THE HUMAN BREAST CANCER CELL LINE IIB-BR-G HAS AMPLIFIED C-MYC AND C-FOS ONCOGENES IN VITRO AND IS SPONTANEOUSLY METASTATIC IN VIVO
CELLULAR AND MOLECULAR BIOLOGY; Año: 1998 vol. 44 p. 493 - 504
CECILIA BALLARE,; MARCELA BARRIO,; PAULA PORTELA; JOSÉ MORDOH
Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells
CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 1995 vol. 41 p. 15 - 22
LAURA BOVER; MARCELA BARRIO,; IRMA SLAVUTSKY; ALICIA I. BRAVO; CARLOS QUINTANS; ANA BAGNATI; BALTASAR LEMA,; JORGE SCHIAFFI,; ROBERTO YOMHA; JOSE MORDOH
Description of a new human breast cancer cell line, IIB-BR-G,established from a primary undifferentiated tumor
BREAST CANCER RESEARCH AND TREATMENT; Año: 1991 vol. 19 p. 47 - 56